Tetra Bio Pharma Inc (OTCMKTS:TBPMF)’s stock price traded down 12.8% during trading on Wednesday . The stock traded as low as $0.27 and last traded at $0.27, 33,740 shares traded hands during mid-day trading. A decline of 60% from the average session volume of 84,003 shares. The stock had previously closed at $0.31.
The firm has a 50 day moving average price of $0.22.
Tetra Bio Pharma Company Profile (OTCMKTS:TBPMF)
Tetra Bio-Pharma Inc, a development stage company, engages in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements in Canada. Its lead product is PPP001, a dried cannabis prescription drug for advanced cancer pain. The company is also developing other cannabis-based drugs for pain management; a series natural health products, including a topical product for pain management; an oral product line for cardiovascular disease prevention, athletic performance, and well-being; a topical product for skin care; a topical product for women; and Munchies B Gone gum.
Recommended Story: Insider Trading – What You Need to Know
Receive News & Ratings for Tetra Bio Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tetra Bio Pharma and related companies with MarketBeat.com's FREE daily email newsletter.